• Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Interleukin Genetics Inc

+ Add to Watchlist


0.1600 USD 0.0065 4.23%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Interleukin Genetics Inc (ILIU)

Open: 0.1537 Day's Range: 0.1537 - 0.1600 Volume: 51,851
Previous Close: 0.1535 52wk Range: 0.1509 - 0.3900 1-Yr Rtn: -55.56%

Stock Chart for ILIU

No chart data available.
  • ILIU:US 0.1600
  • 1D
  • 1M
  • 1Y
Interactive ILIU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILIU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0600
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 19.61
Shares Outstanding (M) 122.55
30 Day Average Volume 12,375
Price/Book (mrq) 8.6124
Price/Sale (ttm) 9.3010
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILIU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILIU

Interleukin Genetics, Inc. develops and commercializes genetic diagnostic tests and medical research tools. The Company's PST, a test predictive of risk for periodontal disease, is currently available in the United States. Interleukin also develops and licenses its medical research tools, such as BioFusion, to pharmaceutical companies for use in drug discovery and development.

Kenneth S Kornman "Ken"Pres/CEO/Chief Scientific OfcrStephen J DipalmaInterim CFO
Scott A SnyderChief Marketing Officer
More Company Profile & Key Executives for ILIU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • ILIU News

  • Industry News

Sponsored Links
sec ||= nil